Navigation Links
Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic Cancer
Date:3/8/2011

VERNON HILLS, Ill., March 8, 2011 /PRNewswire/ -- Genus Oncology, LLC, a clinical-stage company focused on commercializing novel drugs for treatment of cancer, announced it has received an Orphan Drug Designation from the FDA's Office of Orphan Products Development for its Mucin 1 (MUC1) targeting peptide, GO-203-2c, for the treatment of pancreatic cancer.

Orphan Drug Designation, as granted by the US Orphan Drug Act, is for a product that treats a rare disease or condition affecting fewer than 200,000 people in the US. According to the National Cancer Institute, there are approximately 31,000 people diagnosed with pancreatic cancer in the US annually, and approximately 220,000 worldwide. Orphan Drug Designation qualifies the sponsor of the product for tax credits and seven years of marketing exclusivity, among other benefits.  

"Treatment of pancreatic cancer represents a significant unmet medical need," said Stephen Thompson, CEO and President of Genus Oncology. "Pancreatic cancer is the fourth most common cause of cancer-related deaths in the Western world, and survival rates of patients diagnosed with pancreatic cancer have not changed in decades despite advances in treatment options. Based on our results of treating pancreatic cancer in preclinical models, we believe our MUC1 targeting technologies have the potential to significantly impact the treatment and outcomes of this difficult to treat disease."

GO-203-2c, Genus' lead drug candidate, is currently being studied in a Phase I trial that is designed to determine the safety and tolerability, and potential anti-tumor activity of the drug. The sites currently contracted to conduct the Phase I trial are the University of Texas Health Science Center at San Antonio (UTHSCSA) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare. Additional sites are currently under consideration.

About GO-203-2c

GO-203-2c is the optimized lead peptide drug candidate f
'/>"/>

SOURCE Genus Oncology, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Genus Oncology, LLC Announces Initiation of Phase I Trial of GO-203-2c in Patients With Solid Tumors
2. US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 The global ... USD 49.12 billion by 2020, growing at a CAGR ... new report by Grand View Research, Inc. Monitoring services ... 49.7% from 2014 to 2020.      (Logo: ... along with rising incidences of chronic diseases such as ...
(Date:8/27/2015)... 27, 2015 ieCrowd™ today announced the ... development of the company,s supplemental oxygen delivery device, ... being developed by ieCrowd,s subsidiary Smart Oxygen Solutions ... demand for oxygen based on level of activity.  ... for the Smart Oxygen device would require a ...
(Date:8/27/2015)... , Aug. 27, 2015   Proxsys ... Provider (IOPP™) is expanding its population health ... medication-focused transition of care program for hospitals ... Management," provides hospitals with technology systems and ... measures that have been mandated by Center ...
Breaking Medicine Technology:mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
... Lilly and Company (NYSE: LLY ) has ... for Working Mothers by Working Mother magazine ... http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO) (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO) Celebrating its ... 100 Best Companies initiative selects the nation,s top companies ...
... Wolters Kluwer Health , a leading provider of information ... medicine, nursing, allied health and pharmacy, has announced an ... (JBI), a recognized global leader in evidence-based healthcare resources ... of an expansion of the nursing, allied health, and ...
Cached Medicine Technology:Lilly Celebrates 16th Consecutive Year as One of 100 Best Companies for Working Mothers 2Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources 2Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources 3Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources 4
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... On October 3, 2015, BethAnn Telford of ... North Rim of the Grand Canyon with a shared mission: to beat brain cancer. ... canyon floor, across the canyon, then up to the South Rim over 21.1 miles and ...
(Date:8/27/2015)... ... August 27, 2015 , ... Keck Graduate Institute (KGI), ... received their White Coats at a formal ceremony recognizing them as members of the ... profession on Saturday, August 22. Symbolizing dedication to clinical service and patient care, the ...
(Date:8/27/2015)... ... August 27, 2015 , ... Workflow in labs has ... (qPCR) in the last decade. New features such as multiplexing, microfluidics, and ... flipside, where do lab managers, technicians, and researchers find handy metrics to compare ...
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny ... of just 20 adult-only medical centers in the United States to receive international ... and lungs. The Extracorporeal Life Support Organization (ELSO) , an international consortium ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... The Naderi ... now be offering Kybella, a cutting-edge, noninvasive procedure to improve submental fat. The ... Kybella provides permanent results without surgery. Dr. Kulak is the only Board Certified ...
Breaking Medicine News(10 mins):Health News:Women Athletes Cross the Grand Canyon to Raise Funds for Brain Cancer Research – October 3rd 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 3Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 4Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3
... holds press conferenceEPHRATA, Pa., April 29 Did ... diagnosed with breast cancer in Pennsylvania who are uninsured or ... - are not aware of the program or how it ... Breast Cancer Coalition (PBCC), in partnership with Senator Vince Hughes, ...
... Up Its ActNEW YORK, April 29 Today, Senator ... by introducing the Safe Baby Products Act, which directs ... contaminants in personal care products marketed to or used ... study by the Campaign for Safe Cosmetics, which revealed ...
... as the lead organizational and strategic planning consultant. Led by General ... of the new healthcare delivery organization. , ... (PRWEB) April 29, 2009 ... care hospital. The hospital will be part of a health village ...
... -- Aesthetic Medical Educators Training (AMET) ... on Aesthetic Procedures over the past five years. ... physicians, nurses, physician assistants and dentists, all of ... practice.These medical professionals have been trained on a ...
... CITY, April 29 Grupo Aeroportuario del Sureste, S.A.B. ... the first privatized airport group in Mexico and operator ... Mexico, announced today that on April 26, 2009 the Mexican ... ("Swine Flu") in Mexico. On April 28, 2009 the World ...
... Controls Limit Vaccine SuppliesDALLAS, April 29 Fears of ... new vaccines, as well as meeting public demand for ... National Center for Policy Analysis. "We are facing ... six vaccines for common childhood illnesses," said NCPA Senior ...
Cached Medicine News:Health News:Free Treatment for Breast Cancer Available in Pennsylvania 2Health News:New Federal Legislation Targets Toxic Chemicals in Baby Bath Products 2Health News:Aesthetic Medical Educators Training Successfully Trains Over 2,000 Medical Professionals on Aesthetic Procedures 2Health News:Swine Flu Outbreak Illustrates Problems in Vaccine Development 2
... Top Rotation provides uncommon bi-directional flexibility, ... Hercules 6700B eliminates any conflicts between ... while providing ample leg room for ... procedures. Removable back and leg sections ...
... The schaerer axis 800 ... specially designed for those ... C-arm access. The stability, ... and the offset positioned ...
... operating table for any application. The ... unlimited C-arm access. High stability guarantees ... and cardiovascular procedures. An extension device ... can easily be attached for orthopedic ...
... The anatomy of the human body set ... new arcus-family. Thanks to the special concept of ... in all positions ergonomically adapts to the patient ... available when the C-arm is being utilised. The ...
Medicine Products: